Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2002, p. 3460-3473, Vol. 22, No. 10
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.10.3460-3473.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Ming-Ming Jiang,2 and David B. Roth1,2*
Department of Immunology,1 Howard Hughes Medical Institute, Baylor College of Medicine, Houston, Texas 770302
Received 24 September 2001/ Returned for modification 30 November 2001/ Accepted 7 February 2002
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Both RAG proteins are required for all steps of the recombination reaction, but little is known about the specific role(s) played by each protein. At a single RSS, RAG-1 binds as a dimer, with one or two monomers of RAG-2 (4, 50, 64). Recent work has shown that only one functional active site contained within one RAG-1 monomer is required for both catalytic steps (cleavage and hairpin formation) at a single RSS (32, 62). Site-directed mutagenesis of all evolutionarily conserved acidic amino acids of truncated active core RAG-1 and RAG-2 (the minimal regions of the proteins required for efficient recombination) revealed that RAG-1 contains three acidic active-site amino acids (33) thought to be responsible for coordinating catalytic metal ions (16, 30, 33). Thus, RAG-1 contains at least part of the active site of the recombinase.
Deletion analysis has provided other information about important regions of the RAG-1 protein. The N terminus contains a DNA-binding domain that interacts with the nonamer element (12, 59). RAG-1 also contacts DNA at the border between the heptamer and the adjacent coding sequence (14, 42, 64); recent DNA-protein cross-linking studies have indicated that the region responsible for these contacts resides in the C terminus of RAG-1 (44). Deletion analysis has revealed extensive regions of RAG-1 that interact with RAG-2 (2, 40), but specific amino acids important for this interaction have not been identified.
Basic amino acids are often involved in DNA binding and protein-protein interactions. In transposases and restriction enzymes, basic residues position the substrate for cleavage or stabilize the transition state of the reaction (reviewed in references 22 and 56). Site-directed mutational analyses of all conserved positively charged amino acids in core RAG-2 failed to identify catalytic amino acids (15, 47). To search for such catalytic amino acids in RAG-1 and to better define other functional regions of RAG-1, we mutated all 86 evolutionarily conserved basic amino acids in RAG-1 to alanine (Fig. 1) and evaluated the mutant proteins for their ability to carry out DNA binding, nicking, hairpin formation, and joining.
|
| MATERIALS AND METHODS |
|---|
|
|
|---|
N (58), by double-stranded mutagenesis (11) for protein purification. The entire open reading frames of all mutants constructed with pEBG-1
N were sequenced. Despite repeated attempts, one mutant, H482/K483, could not be generated with the GST-RAG-1 fusion expression vector.
|
PCR assays for coding and signal joints. To detect coding joints and signal joints, 1/30th of the total harvested DNA was assayed by PCR (24 cycles). Coding and signal joints on the excised products of pJH289 and pJH290 were amplified with primers DR55 and ML68 as described previously (61). Coding joints formed on the plasmid product from pJH290 were amplified with primers DR99 and DR100 (21). Coding joints and signal joints formed on the pJH299 substrate were amplified with primers ML68 and DR99 and primers DR55 and DR100, respectively. PCR products (10 µl) were separated on a 6% polyacrylamide gel, transferred to a membrane (Genescreen Plus), and hybridized with a radiolabeled oligonucleotide probe (DR55 or DR99).
Ligation-mediated PCR for detection of signal ends. One-thirtieth of the harvested DNA was assayed by ligation-mediated PCR as described previously (60). For PCR assays, 1 µl of a 1:100 dilution of the ligation mixture was amplified with primers DR55 and DR20. PCR products were separated on a 6% polyacrylamide gel, transferred to a membrane, and hybridized with a radiolabeled oligonucleotide probe (DR69) (60).
Transformation assay for detection of coding and signal joints. Coding joints and signal joints formed on the plasmid products from the pJH290 and pJH289 substrates were detected as chloramphenicol-resistant colonies as described previously (23).
Analysis of coding and signal joint sequences. PCR products containing the coding joint from pJH289 were gel purified and cloned by using a Topo TA cloning kit (Invitrogen). Positive colonies were identified by colony PCR screening, and the PCR products were sequenced by using a BigDye terminator cycle sequencing kit (version 2.0; PE Biosystems). Sequences for coding joints for RAG-1 mutants were obtained from three independent transfections. The structures of signal joints were determined by digesting PCR products containing the signal joint from pJH290 with 20 U of ApaLI at 37°C for 3 h.
Purification of GST fusion proteins.
The wild-type or mutant GST-RAG-1 expression vector (pEBG-1
N) and the wild-type GST-RAG-2 expression vector (pEBG-2
C) (58) were cotransfected into RMP41 cells. The GST-RAG-1 and GST-RAG-2 proteins were copurified as described previously (47, 52, 54). Protein concentrations were determined by Coomassie blue staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Multiple preparations of mutant R471 yielded only very low quantities of protein, so we were unable to assay this mutant in vitro. Note that for all biochemical assays, estimations of the relative activities of the mutant proteins were made based on comparisons to the activities of wild-type control protein preparations assayed at the same time and run on the same gel.
DNA-binding assays. DNA-binding assays with a single radiolabeled 12-RSS substrate (DAR39/40) (39) and the copurified GST-RAG-1 and GST-RAG-2 proteins were performed as described previously (25). DNA binding was analyzed by nondenaturing electrophoresis through a 4 to 20% polyacrylamide gel in Tris-borate-EDTA and visualized by using a PhosphorImager (Molecular Dynamics).
Oligonucleotide cleavage assays. Coupled cleavage of oligonucleotide substrates was performed as described previously (25) but with some modifications. Briefly, the purified RAG proteins (2 µl) were incubated with 25 fmol of radiolabeled 12-RSS oligonucleotide substrate (DAR39/40) and 250 fmol of unlabeled 23-RSS (or unlabeled 12-RSS, when needed) substrate (DG61/62) (39) in a 10-µl volume containing 25 mM morpholinepropanesulfonic acid (MOPS) (pH 7.0), 2 mM dithiothreitol, 100 µg of bovine serum albumin/ml, 5 mM CaCl2, 19 mM potassium acetate, and 200 ng of high-mobility group protein 1 (HMG-1). Histidine-tagged, full-length recombinant human HMG-1 was purified from bacteria containing the plasmid pET-HMG (18). Reaction mixtures were incubated for 10 min at 37°C. MgCl2 was added to a final concentration of 5 mM, and the reaction mixtures were incubated for an additional 20 min at 37°C. Reactions were terminated by the addition of an equal volume of formamide loading dye. Products were resolved on a 10% acrylamide gel containing 30% formamide, 0.67x Tris-borate-EDTA, and 12.5 mM HEPES (pH 7.5) and visualized by using a PhosphorImager. Oligonucleotide substrates with nonpermissive coding flank sequences were created by annealing SK5/SK6 (12 RSS) and SK38/SK39 (23 RSS) (28). All oligonucleotides were gel purified prior to labeling and annealing.
Cleavage at a single RSS and cleavage of a prenicked substrate were performed as described for coupled cleavage but with the following modifications: The purified RAG proteins were incubated with the 12-RSS oligonucleotide substrate or the prenicked substrate, which was made by annealing DAR42 (32P end labeled), DG10, and DAR40 (39). MnCl2 was substituted for MgCl2, and HMG storage buffer (25 mM Tris-Cl [pH 8.0], 1 mM EDTA, 1 mM dithiothreitol, 150 mM KCl, 10% glycerol) replaced HMG-1.
| RESULTS |
|---|
|
|
|---|
Thirty-eight mutants were proficient for recombination, forming signal and coding joints at
10% wild-type levels, and 3 mutants consistently exhibited moderate recombination defects, giving between 2 and 10% wild-type levels of recombination. The 27 remaining mutants were severely defective, giving
1% recombination in multiple experiments. Eight of these mutants were reconstructed in the context of full-length, untagged RAG-1 and tested in combination with full-length RAG-2. No decrease in the severity of the in vivo recombination defects was observed (Table 1). Two mutants, R391 and R393, were studied previously; they affect critical amino acids in a domain with homology to hin recombinase, which has been implicated in binding to the nonamer (12, 59). As expected, we found these two mutants severely defective for recombination (Table 1) and did not study them further.
We determined the effects of the 25 remaining mutants on cleavage in vivo by using an established semiquantitative ligation-mediated PCR assay for signal ends (60). Twenty-one mutants were severely (at least 100-fold) defective for cleavage (Table 2). Four mutants produced levels of signal ends within 10-fold wild-type levels (Table 2) (see below) and thus were specifically defective for the joining phase of the reaction.
|
|
3-fold) binding defects (R401/R402, R440, R838/K839/R840, R855/K856, and K890) (Fig. 2, lanes 2, 4, 15, 16, and 17), which did not substantially affect their ability to nick the DNA or, in some cases, to form hairpins (see below).
|
|
(ii) Group 2 mutants showed impaired nicking. We next examined the ability of the purified mutant proteins to perform coupled cleavage at an RSS pair. Mutant proteins were incubated in Mg2+ with radiolabeled 12-RSS substrate and an unlabeled 23-RSS oligonucleotide. Under these conditions, efficient hairpin formation requires a 12-RSS-23-RSS pair, but nicking does not (25) (Fig. 3A, compare lanes 1 and 2). Six mutants that were capable of RSS binding displayed catalytic defects and were unable to efficiently nick the DNA substrate (Fig. 3A, lanes 11 to 16): K596, R621, R713, R734, H795, and K989/H990/H991.
To determine whether these mutants are capable of catalysis under relaxed conditions, we examined cleavage in Mn2+, which allows nicking and hairpin formation at a single RSS. Mn2+ partially restored nicking and/or hairpin formation by K596, R734, and K989/H990/H991 (Fig. 4, compare lane 1 with lanes 5 to 7), indicating that these amino acids are not absolutely required for catalysis. Three mutants (R621, R713, and H795) remained unable to nick or form hairpins (Fig. 4, lanes 2 to 4). Because nicking is a prerequisite for hairpin formation, these three mutants were tested for their ability to form hairpins with a prenicked oligonucleotide substrate in Mn2+. Under these conditions, R621 was able to form hairpins at nearly wild-type levels (Fig. 5, lane 2); its defect, therefore, is specifically in the nicking step. R713 and H795, however, remained defective for both nicking and hairpin formation (Fig. 5, lanes 3 and 4). Thus, these two mutants, while proficient for DNA binding, are defective for cleavage. These data suggest that R713 and H795, like the previously identified acidic triad (D600, D708, and E962), play critical roles in the catalysis of both cleavage steps.
|
|
Mn2+ completely restored catalytic activity to one hairpin-defective mutant, R972/K973 (Fig. 4, lane 11), indicating that it is not completely defective for the ability to perform transesterification. The remaining three hairpin-defective mutants (R855/K856, K890, and R894) formed aberrant hairpins in Mn2+ (Fig. 4, compare lane 1 with lanes 8 to 10). Although the wild-type protein forms some abnormal hairpins in Mn2+, the mutants produce a higher proportion of aberrant hairpins. These mutants may have difficulty positioning the 3' OH for hairpin formation; alternatively, aberrant hairpins may result from aberrant nicking followed by correct hairpin formation. When a correctly positioned nick was provided by a prenicked substrate, R855/K856, K890, and R894 formed approximately equal proportions of perfect and aberrant hairpins (Fig. 5, lanes 5 to 7), although the levels of hairpins remained lower than those seen with the wild type. These results support the hypothesis that these mutants have difficulty positioning the 3' OH of the nicked strand for transesterification.
(iv) A group 4 mutant showed a conditional defect in hairpin formation. One mutant, K608, was severely defective for cleavage in vivo. When tested in vitro, however, it cleaved proficiently (Fig. 3A, compare lanes 2 and 21). We considered the possibility that this difference might result from differences in the substrates used in the two assays. The in vivo substrates contain nonpermissive coding flank sequences that block hairpin formation by two other mutants with mutations located in the same region of RAG-1 (between amino acids 606 and 611), whereas the in vitro experiments were done with oligonucleotides with permissive coding flank sequences that allow hairpin formation by these mutants (28).
We therefore tested the ability of K608 to cleave an oligonucleotide substrate containing the same nonpermissive coding flank sequence as that found in the plasmid (5'-TCGAC-heptamer) in vitro. With this substrate, K608 exhibited defective hairpin formation (Fig. 3B, compare lanes 2 and 3). In agreement with these results, the purified K608 protein was able to cleave plasmid substrates with permissive but not nonpermissive coding flank sequences (data not shown). Mutant K608 thus exhibits a conditional defect in hairpin formation with certain coding flank sequences. It is not clear why this defect was not observed in earlier in vivo studies of this mutant (51).
(v) Group 5 mutants showed joining defects. The fifth group contains four joining-deficient mutants (R401/R402, R440, R838/K839/R840, and K980). We tested these mutants by using three types of recombination substrates: those that form coding and signal joints by inversion, those that retain coding joints on the plasmid, and those that retain signal joints on the plasmid (diagrammed in Fig. 6A). All four mutants displayed mild in vivo cleavage defects, with approximately 10-fold decreases in the levels of signal ends (Fig. 6F, Table 2, and data not shown).
|
100-fold) joining defects in coding and signal joint formation with all three substrates (Fig. 6B to E and G, lanes 4 and 5). R838/K839/R840 and K980, however, were only mildly defective (approximately 10-fold) for signal joint formation (Fig. 6C and E, lanes 6 and 7). This defect in signal joint formation can be largely accounted for by the partial (10-fold) cleavage defect exhibited by these mutants (Fig. 6F, lanes 4 to 7). These two mutants were severely defective (
100-fold) for the formation of coding joints with the pJH299 substrate, which recombines by inversion (Fig. 6B, lanes 6 and 7), and the pJH290 substrate, which generates coding joints on the plasmid product (Fig. 6G, lanes 6 and 7). Interestingly, these mutants were only mildly defective (approximately 10-fold) for coding joint formation on the small excised product of pJH289 (Fig. 6D, lanes 6 and 7), suggesting that the defect in coding joint formation can be modified by the configuration of the substrate. A smaller but reproducible increase in signal joint formation was also observed on the excised product.
To confirm these results, we used a standard bacterial transformation assay to detect the plasmid products of V(D)J recombination (23). The measurement of signal joints formed by R838/K839/R840 and K980 from pJH289 revealed that both mutants form signal joints at 5 to 10% wild-type levels (Fig. 6I), consistent with the magnitude of the cleavage defect (Fig. 6F) and the results of PCR assays for signal joints on the inversion substrate (Fig. 6C). Coding joint formation on the pJH290 substrate, however, was severely defective (1% wild-type levels or less) (Fig. 6H), in agreement with the PCR results. Thus, these mutants displayed more severe defects in coding joint formation on the plasmid product (
1% recombination) than on the excised product (
10% recombination). This result could be related to the relatively short distance between the ends of the excised product (
250 nucleotides [nt]), which may allow partial rescue of the joining defect by promoting end-to-end associations (see Discussion).
Another interesting feature of coding joints formed on the excised product by these mutants is the smearing of the coding joint products (Fig. 6D, lanes 6 and 7), which was observed in multiple experiments and suggested the presence of junctions with excessive deletions. To test this hypothesis, we performed nucleotide sequence analysis of cloned coding joints derived from the excised product. Whereas 90% of wild-type coding joints lose less than 10 nt (Fig. 7 and 8A) (65), analysis of 76 coding joints from R838/K839/R840 and K980 revealed that 60 to 70% of the junctions showed deletions of greater than 10 nt, with many junctions losing more than 20 nt (Fig. 7 and 8B). These data suggest that certain RAG-1 mutations cause the coding ends to be abnormally exposed to nucleolytic degradation. Notably, the signal joints formed in the presence of these mutants were generally perfect, without addition or loss of nucleotides (data not shown), indicating that excessive deletions were specific to the coding joints.
|
|
5% of the junctions produced by the K980 mutant provides strong evidence that the mutation in this RAG-1 mutant causes abnormal hairpin opening. Another feature characteristic of coding joints formed in double-strand break repair-deficient cells, including cells lacking DNA-PKcs, is the frequent presence of short sequence homologies (5, 37). Although only 10% of coding joints made by wild-type RAG proteins exhibit junctional homologies (Fig. 8C), 40 to 50% of the junctions made by R838/K839/R840 and K980 contain short sequence homologies (Fig. 8C). These data suggest that coding joint formation by these mutants may be facilitated by base-pairing interactions. Finally, a large fraction of the coding joints made by mutant K980 contain large insertions of random DNA, another feature characteristic of coding joints made in Ku- and DNA-PKcs-deficient cells (5, 65).
To gain further insights into the mechanisms of the joining defects, all four mutants were examined biochemically as purified proteins. As expected, all were capable of both nicking and hairpin formation in vitro (Fig. 3A, lanes 22 to 25), with only mild defects that reflect the modest decrease in signal ends observed in vivo. All mutants transposed signal ends at wild-type levels in vitro (data not shown), indicating that the mutant RAG proteins remain associated with the signal ends after cleavage in a postcleavage complex. Furthermore, as observed previously with some coding joint-deficient RAG mutants (47, 54), all four joining mutants opened oligonucleotide hairpins in a standard hairpin opening assay performed in Mn2+ (data not shown). Nevertheless, the specific defect in coding joint formation, along with the presence of excessive P nucleotide insertions, strongly suggests that mutant K980 is defective for hairpin opening in vivo. Clearly, while the in vitro assay (which tests the opening of artificial hairpins in Mn2+) is capable of detecting mutants that lack the catalytic capability to open hairpins (47, 54), it does not recapitulate all physiologically relevant aspects of this reaction (such as its dependence upon DNA-PK in vivo). Thus, we suggest that the K980 mutation impairs a regulatory aspect of the hairpin opening reaction, such as the ability of the postcleavage complex to interact with DNA-PK.
| DISCUSSION |
|---|
|
|
|---|
Besides binding to the nonamer, the RAG complex must also contact the heptamer and the DNA at the border of the cleavage site. Recent DNA-protein cross-linking studies have suggested that the C terminus of RAG-1, specifically a region between methionine residues 889 and 974, contacts the DNA at the coding flank (44). Our data show that several basic residues within this region (H937/K938, H942, K966, and R969/R970) are essential for DNA binding. One additional mutation, R977, which lies just outside this region, also causes a moderate binding defect. Importantly, these mutants retain the ability to interact with RAG-2, suggesting that they are specifically defective for DNA-protein interactions (although we cannot completely rule out the possibility that some of these mutants may have defects in RAG-1 dimerization). Together, these data support a role for the C terminus of RAG-1 in DNA binding and identify specific basic residues that contribute to binding.
The region of RAG-1 encompassing the C2H2 zinc-binding domain (amino acids 723 to 754), termed ZFB, is involved in nonspecific DNA binding (49) and RAG-2 interactions (2). Residues R748 and H750 are located in the zinc finger region, and H750 is predicted to help coordinate zinc. Mutation of the cysteine or histidine ligands in a zinc finger most often results in a loss of function (68). We found that the R748/H750 mutant is defective for DNA binding but maintains the ability to interact with RAG-2, suggesting that the zinc finger is essential for DNA binding but perhaps not for RAG-2 interaction.
Step arrest mutants that specifically block nicking or hairpin formation. Although three active-site residues, D600, D708, and E962, are required for both nicking and hairpin formation (16, 30, 33), each of these steps is likely to also involve some distinct active-site amino acids. Our R621A mutant is severely and specifically defective for nicking, in agreement with recent studies of R621H, which was found in patients with B-cell-negative SCID (35). We also identified two classes of mutants with specific defects in hairpin formation. The first class consists of the K608A mutant, which is defective for hairpin formation in the presence of certain nonpermissive coding flank sequences. Two other mutations located between amino acids 606 to 611 share similar properties and, like K608A, have been implicated in generating a distorted DNA intermediate required for hairpin formation (28).
The second class of hairpin-defective mutants contains four mutants (R855/K856, K890, R894, and R972/K973) with novel phenotypes. Unlike the RAG-1 mutants described above, these mutants are not sensitive to the coding flank sequence and are not rescued by coding flank sequences containing mismatches; their defect in hairpin formation is not obviously related to problems with distortion of the DNA at the cleavage site. Three of these mutants (R855/K856, K890, and R894) remain defective for accurate hairpin formation even under relaxed cleavage conditions (in Mn2+) that allow efficient hairpin formation at a single RSS. Interestingly, all three mutants form hairpins at aberrant locations in Mn2+, even with a prenicked substrate. These data suggest that they are unable to correctly position the attacking nucleophile (the 3' OH) in the transesterification reaction. Other related systems, such as human immunodeficiency virus type 1 integrase and Tn5, use basic residues to position the DNA close to the active site (10, 26). Perhaps R855/K856, K890, and R894 serve a similar role in RAG-1.
Catalytic residues important for both nicking and hairpin formation. Structural analyses of the active sites of several transposases and integrases have revealed the presence of basic amino acids (6, 10, 22). Mutational analysis of these residues has shown that they are essential for both cleavage and strand transfer (6, 22, 26). In addition to orienting the DNA in the active site, basic residues in Tn5 play a role in catalysis by stabilizing a DNA bend (10). Our analysis revealed two residues in RAG-1 (R713 and H795) that, when mutated, produce severe defects in both nicking and hairpin formation without affecting DNA binding (a defect in nicking by the R713 mutant was reported earlier [30]). Our data indicate that R713 and H795 are essential for the catalysis of both cleavage steps.
Basic residues in RAG-1 that are required for joining. We identified four RAG-1 mutants (R401/R402, R440, R838/K839/R840, and K980) that specifically affect the joining phase of V(D)J recombination. All four mutants are severely impaired for coding joint formation; two mutants (R401/402 and R440) also have a block in signal joint formation. Like other recently described RAG-1 and RAG-2 joining-deficient mutants which are specifically defective for both coding and signal joint formation, R401/R402 and R440 retain the ability to open artificial hairpins in vitro (47, 54). These mutants may be defective for recruiting joining factors, as their joining phenotype is similar to that observed in Ku- and XRCC4-deficient cells.
The remaining two joining mutants identified in this study (R838/K839/R840 and K980) share two novel phenotypes. The first of these is the differential effect of substrate length on coding joint formation (and, to a lesser degree, signal joint formation). A salient feature of the excised product, which permits coding joint formation, is the short distance between the coding ends (
250 nt). This short distance may facilitate joining by increasing the probability of end-end interactions. Support for this hypothesis is provided by studies of intramolecular ligation, which have shown that recircularization is favored at substrate lengths of between a few hundred to approximately 1,000 bp; above these lengths, the ends begin to behave as if they are on separate DNA molecules (57).
The second novel phenotype of these mutants is their effect on the structure of the coding joints that can be recovered. The sequences of these joints are distinctly abnormal, with features characteristic of the rare junctions recovered from cells bearing double-strand break repair mutations, including excessive deletions and short sequence homologies at the junctions. Previous RAG joining mutations had not been found to affect the structure of these junctions (47, 54). The observation that mutations in RAG-1 and double-strand break repair factors affect the structure of coding joints in similar ways provides strong support for the idea that the RAG proteins are intimately involved in the joining process. These RAG-1 mutants may release coding ends prematurely or exhibit defects in recruiting one or more of the nonhomologous end-joining factors, leaving the coding ends to be joined by alternative repair pathways that allow more exonucleolytic degradation. The observation that the only coding joints that could be recovered from these two RAG-1 mutants are formed on the short excised product and frequently use short sequence homologies suggests that the alternative joining pathways require assistance in aligning the ends for joining. Thus, one important function of the RAG proteins in the postcleavage complex may be to serve as a scaffold to assist end joining.
The phenotypes of these two RAG-1 mutants share many striking parallels with the effects of DNA-PKcs deficiency on V(D)J recombination, including the effects on the junction structures noted above and also the fact that coding joints are more severely affected than signal joints. As noted above, the abnormally long P nucleotide inserts observed in coding joints formed by K980 are characteristic of coding joints recovered from cells lacking DNA-PKcs and suggest a defect in hairpin opening. These observations provide strong evidence that the RAG proteins play a role in hairpin opening in vivo and suggest that the RAG proteins and DNA-PKcs collaborate in the joining process.
Refining the functional map of RAG-1. Mapping of mutations along the RAG-1 primary sequence revealed several phenotypic classes that cluster in specific regions of the sequence (Fig. 9). Hairpin-defective mutants implicated in DNA distortion lie in the region of amino acids 606 to 611, which is near the active-site residue, D600. Two joining-deficient mutants with defects in both coding and signal joint formation (R401/R402 and R440) are located in the N terminus, where two previously identified RAG-1 joining mutants (E423Q and E547Q) are also found (54). Furthermore, we found a cluster of joining mutants in the C terminus of the protein, including the R838/K839/R840 and K980 mutants. Preliminary analyses of other mutants have revealed three additional joining mutations in the same region of RAG-1 (unpublished observations). These data suggest that RAG-1 contains two domains important for joining: an N-terminal domain that contacts the nonamer and a C-terminal domain that contacts the coding flank. Interestingly, all five C-terminal joining mutants have specific defects in coding joint formation without a significant impairment in signal joints. Thus, the C-terminal domain, which contacts the coding flank prior to cleavage (44), may also play a special role in coding joint formation, perhaps by binding to the hairpin coding ends.
|
Clinical implications. It is interesting that 12 of our recombination-deficient RAG-1 mutations alter residues mutated in patients with inherited immunodeficiency syndromes (7, 55, 66, 67). Clearly, these amino acids are critical for recombination of the endogenous antigen receptor loci in developing lymphocytes. The phenotypes of our alanine substitution mutants suggest that patient mutations may fall into the following functional classes: DNA binding (R393, R407, H750, and R970), nicking (R621, R734, and K989), hairpin-forming (R972), and joining (R401 and R838).
Perhaps even more interesting is the similarity between the effects of our RAG joining mutants and mutants with mutations in DNA-PKcs or other nonhomologous end-joining (NHEJ) factors (defects in coding and signal joint formation or structurally aberrant coding joints). The NHEJ factors were recently designated "genome guardians" because mice lacking DNA-PKcs, Ku70, XRCC4, or Ku80 suffer genomic instability and an increased incidence of lymphomas (9, 13, 17, 20, 27, 38). These lymphomas, in fact, bear characteristic chromosome translocations indicative of mistakes in V(D)J recombination. Like mutations in DNA-PKcs and other NHEJ proteins, RAG joining mutations may increase the frequency of oncogenic DNA rearrangements catalyzed by the V(D)J recombinase.
| ACKNOWLEDGMENTS |
|---|
This work was supported by a grant from the National Institutes of Health (AI-36420). L.E.H was supported by a National Institutes of Health predoctoral fellowship (T32-AI07495). M.M.P. was supported by a fellowship from the Cancer Research Institute. D.B.R. is an Assistant Investigator of the Howard Hughes Medical Institute.
| FOOTNOTES |
|---|
Present address: Cain Project in Engineering and Professional Communication, Rice University, Houston, TX 77251. ![]()
| REFERENCES |
|---|
|
|
|---|
2.
Aidinis, V., D. C. Dias, C. A. Gomez, D. Bhattacharyya, E. Spanopoulou, and S. Santagata. 2000. Definition of minimal domains of interaction within the recombination-activating genes 1 and 2 recombinase complex. J. Immunol. 164:5826-5832.
3.
Akamatsu, Y., and M. A. Oettinger. 1998. Distinct roles of RAG1 and RAG2 in binding the V(D)J recombination signal sequences. Mol. Cell. Biol. 18:4670-4678.
4.
Bailin, T., X. Mo, and M. J. Sadofsky. 1999. A RAG1 and RAG2 tetramer complex is active in cleavage in V(D)J recombination. Mol. Cell. Biol. 19:4664-4671.
5. Bogue, M. A., C. Wang, C. Zhu, and D. B. Roth. 1997. V(D)J recombination in Ku86-deficient mice: distinct effects on coding, signal, and hybrid joint formation. Immunity 7:37-47.[CrossRef][Medline]
6. Bolland, S., and N. Kleckner. 1996. The three chemical steps of Tn10/IS10 transposition involve repeated utilization of a single active site. Cell 84:223-233.[CrossRef][Medline]
7.
Corneo, B., D. Moshous, T. Gungor, N. Wulffraat, P. Philippet, F. L. Le Deist, A. Fischer, and J. P. de Villartay. 2001. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood 97:2772-2776.
8. Cuomo, C. A., C. L. Mundy, and M. A. Oettinger. 1996. DNA sequence and structure requirements for cleavage of V(D)J recombination signal sequences. Mol. Cell. Biol. 16:5683-5690.[Abstract]
9. Custer, R. P., G. C. Bosma, and M. J. Bosma. 1985. Severe combined immunodeficiency in the mouse: pathology, reconstitution, neoplasms. Am. J. Pathol. 120:464-477.[Abstract]
10.
Davies, D. R., I. Y. Goryshin, W. S. Reznikoff, and I. Rayment. 2000. Three-dimensional structure of the Tn5 synaptic complex transposition intermediate. Science 289:77-85.
11. Deng, W. P., and J. A. Nickoloff. 1992. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:81-88.[CrossRef][Medline]
12. Difilippantonio, M. J., C. J. McMahan, Q. M. Eastman, E. Spanopoulou, and D. G. Schatz. 1996. RAG1 mediates signal sequence recognition and recruitment of RAG2 in V(D)J recombination. Cell 87:253-262.[CrossRef][Medline]
13. Difilippantonio, M. J., J. Zhu, H. T. Chen, E. Meffre, M. C. Nussenzweig, E. E. Max, T. Ried, and A. Nussenzweig. 2000. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404:510-514.[CrossRef][Medline]
14.
Eastman, Q. M., I. J. Villey, and D. G. Schatz. 1999. Detection of RAG protein-V(D)J recombination signal interactions near the site of DNA cleavage by UV cross-linking. Mol. Cell. Biol. 19:3788-3797.
15. Fugmann, S., and D. G. Schatz. 2001. Identification of basic residues in RAG2 critical for DNA binding by the RAG1-RAG2 complex. Mol. Cell 8:899-910.[CrossRef][Medline]
16. Fugmann, S. D., I. J. Villey, L. M. Ptaszek, and D. G. Schatz. 2000. Identification of two catalytic residues in RAG1 that define a single active site within the RAG1/RAG2 protein complex. Mol. Cell 5:97-107.[CrossRef][Medline]
17. Gao, Y., D. O. Ferguson, W. Xie, J. P. Manis, J. Sekiguchi, K. M. Frank, J. Chaudhuri, J. Horner, R. A. DePinho, and F. W. Alt. 2000. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404:897-900.[CrossRef][Medline]
18.
Ge, H., and R. Roeder. 1994. The high mobility group protein HMG1 can reversibly inhibit class II gene transcription by interaction with the TATA-binding protein. J. Biol. Chem. 269:17136-17140.
19. Grawunder, U., R. B. West, and M. R. Lieber. 1998. Antigen receptor gene rearrangement. Curr. Opin. Immunol. 10:172-180.[CrossRef][Medline]
20. Gu, Y., K. J. Seidl, G. A. Rathbun, C. Zhu, J. P. Manis, N. van der Stoep, L. Davidson, H.-L. Cheng, J. M. Sekiguchi, K. Frank, P. Stanhope-Baker, M. S. Schlissel, D. B. Roth, and F. W. Alt. 1997. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity 7:653-665.[CrossRef][Medline]
21. Han, J.-O., S. B. Steen, and D. B. Roth. 1997. Ku86 is not required for protection of signal ends or for formation of nonstandard V(D)J recombination products. Mol. Cell. Biol. 17:2226-2234.[Abstract]
22. Haren, L., B. Ton-Hoang, and M. Chandler. 1999. Integrating DNA: transposases and retroviral integrases. Annu. Rev. Microbiol. 53:245-281.[CrossRef][Medline]
23. Hesse, J. E., M. R. Lieber, M. Gellert, and K. Mizuuchi. 1987. Extrachromosomal DNA substrates in pre-B cells undergo inversion or deletion at immunoglobulin V(D)J joining signals. Cell 49:775-783.[CrossRef][Medline]
24. Hiom, K., and M. Gellert. 1997. A stable RAG1-RAG2-DNA complex that is active in V(D)J cleavage. Cell 88:65-72.[CrossRef][Medline]
25. Hiom, K., and M. Gellert. 1998. Assembly of a 12/23 paired signal complex: a critical control point in V(D)J recombination. Mol. Cell 1:1011-1019.[CrossRef][Medline]
26. Jenkins, T. M., D. Esposito, A. Engelman, and R. Craigie. 1997. Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J. 16:6849-6859.[CrossRef][Medline]
27. Jhappan, C., H. C. Morse, R. D. Fleischmann, M. M. Gottesman, and G. Merlino. 1997. DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus. Nat. Genet. 17:483-486.[CrossRef][Medline]
28.
Kale, S. B., M. A. Landree, and D. B. Roth. 2001. Conditional RAG-1 mutants block the hairpin formation step of V(D)J recombination. Mol. Cell. Biol. 21:459-466.
29.
Kienker, L. J., W. A. Kuziel, and P. W. Tucker. 1991. T cell receptor
and
gene junctional sequences in scid mice: excessive P nucleotide insertion. J. Exp. Med. 174:769-773.
30.
Kim, D. R., Y. Dai, C. L. Mundy, W. Yang, and M. A. Oettinger. 1999. Mutations of acidic residues in RAG1 define the active site of the V(D)J recombinase. Genes Dev. 13:3070-3080.
31.
Lafaille, J. J., A. DeCloux, M. Bonneville, Y. Takagaki, and S. Tonegawa. 1989. Junctional sequences of T cell receptor 
genes: implications for 
T cell lineages and for a novel intermediate of V(D)J joining. Cell 59:859-870.[CrossRef][Medline]
32.
Landree, M. A., S. B. Kale, and D. B. Roth. 2001. Functional organization of single and paired V(D)J cleavage complexes. Mol. Cell. Biol. 21:4256-4264.
33.
Landree, M. A., J. A. Wibbenmeyer, and D. B. Roth. 1999. Mutational analysis of RAG-1 and RAG-2 identifies three active site amino acids in RAG-1 critical for both cleavage steps of V(D)J recombination. Genes Dev. 13:3059-3069.
34. Lewis, S. M. 1994. The mechanism of V(D)J joining: lessons from molecular, immunological and comparative analyses. Adv. Immunol. 56:27-150.[Medline]
35.
Li, W., F. C. Chang, and S. Desiderio. 2001. Rag-1 mutations associated with B-cell-negative scid dissociate the nicking and transesterification steps of V(D)J recombination. Mol. Cell. Biol. 21:3935-3946.
36. Li, W., P. Swanson, and S. Desiderio. 1997. RAG-1- and RAG-2-dependent assembly of functional complexes with V(D)J recombination substrates in solution. Mol. Cell. Biol. 17:6932-6939.[Abstract]
37. Li, Z., T. Otevrel, Y. Gao, H.-L. Cheng, B. Seed, T. D. Stamato, G. E. Taccioli, and F. W. Alt. 1995. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell 83:1079-1089.[CrossRef][Medline]
38.
Lim, D. S., H. Vogel, D. M. Willerford, A. T. Sands, K. A. Platt, and P. Hasty. 2000. Analysis of Ku80-mutant mice and cells with deficient levels of p53. Mol. Cell. Biol. 20:3772-3780.
39. McBlane, J. F., D. C. van Gent, D. A. Ramsden, C. Romeo, C. A. Cuomo, M. Gellert, and M. A. Oettinger. 1995. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83:387-395.[CrossRef][Medline]
40. McMahan, C. J., M. J. Sadofsky, and D. G. Schatz. 1997. Definition of a large region of RAG1 that is important for coimmunoprecipitation of RAG2. J. Immunol. 158:2202-2210.[Abstract]
41.
Meier, J. T., and S. M. Lewis. 1993. P nucleotides in V(D)J recombination: a fine-structure analysis. Mol. Cell. Biol. 13:1078-1092.
42.
Mo, X., T. Bailin, S. Noggle, and M. J. Sadofsky. 2000. A highly ordered structure in V(D)J recombination cleavage complexes is facilitated by HMG1. Nucleic Acids Res. 28:1228-1236.
43.
Mo, X., T. Bailin, and M. J. Sadofsky. 1999. RAG1 and RAG2 cooperate in specific binding to the recombination signal sequence in vitro. J. Biol. Chem. 274:7025-7031.
44.
Mo, X., T. Bailin, and M. J. Sadofsky. 2001. A C-terminal region of RAG1 contacts the coding DNA during V(D)J recombination. Mol. Cell. Biol. 21:2038-2047.
45. Moshous, D., I. Callebaut, R. de Chasseval, B. Corneo, M. Cavazzana-Calvo, F. Le Deist, I. Tezcan, O. Sanal, Y. Bertrand, N. Philippe, A. Fischer, and J. P. de Villartay. 2001. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 20:177-186.
46.
Nagawa, F., K.-I. Ishiguro, A. Tsuboi, T. Yoshida, A. Ishikawa, T. Takemori, A. J. Otsuka, and H. Sakano. 1998. Footprint analysis of the RAG protein recombination signal sequence complex for V(D)J type recombination. Mol. Cell. Biol. 18:655-663.
47. Qiu, J., S. B. Kale, H. Y. Schultz, and D. B. Roth. 2001. Separation-of-function mutants reveal critical roles for RAG2 in both the cleavage and joining steps of V(D)J recombination. Mol. Cell 7:77-87.[CrossRef][Medline]
48. Ramsden, D. A., J. F. McBlane, D. C. van Gent, and M. Gellert. 1996. Distinct DNA sequence and structure requirements for the two steps of V(D)J recombination signal cleavage. EMBO J. 15:3197-3206.[Medline]
49. Rodgers, K. K., Z. Bu, K. G. Fleming, D. G. Schatz, D. M. Engelman, and J. E. Coleman. 1996. A zinc-binding domain involved in the dimerization of RAG1. J. Mol. Biol. 260:70-84.[CrossRef][Medline]
50.
Rodgers, K. K., I. J. Villey, L. Ptaszek, E. Corbett, D. G. Schatz, and J. E. Coleman. 1999. A dimer of the lymphoid protein RAG1 recognizes the recombination signal sequence and the complex stably incorporates the high mobility group protein HMG2. Nucleic Acids Res. 27:2938-2946.
51.
Roman, C. A. J., and D. Baltimore. 1996. Genetic evidence that the RAG1 protein directly participates in V(D)J recombination through substrate recognition. Proc. Natl. Acad. Sci. USA 93:2333-2338.
52.
Sawchuk, D. J., F. Weis-Garcia, S. Malik, E. Besmer, M. Bustin, M. C. Nussenzweig, and P. Cortes. 1997. V(D)J recombination: modulation of RAG1 and RAG2 cleavage activity on 12/23 substrates by whole cell extract and DNA-bending proteins. J. Exp. Med. 185:2025-2031.
53. Schuler, W., N. R. Ruetsch, M. Amsler, and M. J. Bosma. 1991. Coding joint formation of endogenous T cell receptor genes in lymphoid cells from scid mice: unusual P-nucleotide additions in VJ-coding joints. Eur. J. Immunol. 21:589-596.[Medline]